Updated Jul 16, 2026
Scott Randal W. has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $1.43M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-05-19 | BBIO | BridgeBio Pharma, Inc. | S — Open-market sale | 200 | $69.12 | $14K |
| 2026-05-19 | BBIO | BridgeBio Pharma, Inc. | S — Open-market sale | 1.5K | $68.23 | $103K |
| 2026-05-19 | BBIO | BridgeBio Pharma, Inc. | S — Open-market sale | 2.1K | $67.53 | $141K |
| 2026-05-19 | BBIO | BridgeBio Pharma, Inc. | S — Open-market sale | 6.2K | $66.69 | $413K |
| 2026-05-19 | BBIO | BridgeBio Pharma, Inc. | M — Option exercise | 10.0K | $16.75 | $168K |
| 2026-02-18 | BBIO | BridgeBio Pharma, Inc. | S — Open-market sale [10b5-1] | 3.3K | $75.93 | $251K |
| 2026-02-18 | BBIO | BridgeBio Pharma, Inc. | S — Open-market sale [10b5-1] | 4.8K | $75.57 | $362K |
| 2026-02-18 | BBIO | BridgeBio Pharma, Inc. | S — Open-market sale [10b5-1] | 1.9K | $74.34 | $141K |
| 2026-02-18 | BBIO | BridgeBio Pharma, Inc. | M — Option exercise [10b5-1] | 10.0K | $16.75 | $168K |
Scott Randal W. is a corporate insider — currently tracked as Director of BridgeBio Pharma, Inc. (BBIO). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 7 open-market sales ($1.43M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Scott Randal W. profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.